Mode
Text Size
Log in / Sign up

VitoCheck EIT platform predicts standard diagnostics for cardiopulmonary and metabolic diseasesA new device predicts heart and lung health without needing a specialist

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider VitoCheck EIT as a preliminary tool for remote screening of cardiopulmonary and metabolic diseases.

This cohort study in community settings evaluated the VitoCheck compact electrical impedance tomography platform for predicting standard diagnostic metrics. The population included clinical cohorts with chronic cardiopulmonary, metabolic, and renal diseases. The intervention was the VitoCheck platform, and the comparator was standard diagnostic metrics including spirometry, echocardiography, ultrasound, and blood serum tests.

The main results showed accurate EIT-based predictions of spirometry-derived forced expiratory volumes for lung function, echocardiography-derived ejection fraction for heart function, ultrasound-derived liver fat scores for liver function, and blood serum-derived kidney filtration for kidney function. No effect sizes, absolute numbers, p-values, or confidence intervals were reported for these outcomes.

Safety and tolerability were not reported, including adverse events, serious adverse events, and discontinuations. Key limitations include that system stability, spatial specificity, and spectral sensitivity were demonstrated only through controlled phantom studies.

Practice relevance includes enabling scalable screening and proactive disease management for use in remote and out-of-clinic care. The evidence is preliminary and based on observational cohort data without reported quantitative performance metrics.

People with chronic heart, lung, kidney, or liver diseases often struggle to get quick answers in remote areas. Standard tests like spirometry or echocardiography require trained staff and expensive equipment. A new compact platform called VitoCheck aims to change this. It uses electrical signals to measure internal body changes without invasive procedures. The goal was to match the accuracy of standard hospital tests while working in community clinics. The study looked at how well this device predicted results for lung function, heart function, liver fat, and kidney filtration. It compared its readings against standard metrics like spirometry, ultrasound, and blood serum tests. The results showed the device made accurate predictions for all four areas. It also worked well when non-specialists operated it. This suggests the technology could help manage diseases proactively outside large hospitals. However, the team tested system stability and sensitivity using controlled phantom studies rather than real patients. This means the real-world performance in diverse clinical environments needs further confirmation. Despite this, the potential for scalable screening in out-of-clinic care is significant.

What this means for you:
A compact device accurately predicts standard heart and lung tests for remote care.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Chronic cardiopulmonary, metabolic, and renal diseases represent an immense global health burden, yet access to organ-specific diagnostics remains limited outside of hospitals. Most clinical assessments rely on imaging or laboratory testing that is costly, infrastructure-dependent, and impractical for large-scale or longitudinal monitoring in community settings. Here, we introduce VitoCheck, a compact, user-friendly electrical impedance tomography (EIT) platform that provides non-invasive evaluation of lung, heart, liver, and kidney function within minutes. We first demonstrate system stability, spatial specificity, and spectral sensitivity through controlled phantom studies. We then validate VitoCheck in clinical cohorts by demonstrating accurate EIT-based predictions of standard diagnostic metrics, including spirometry-derived forced expiratory volumes, echocardiography-derived ejection fraction, ultrasound-derived liver fat scores, and blood serum-derived kidney filtration. User feedback further highlights the rapid scan workflow that supports deployment by non-specialists in decentralized environments. By combining portable and easy-to-use hardware with quantitative organ health analytics, VitoCheck enables scalable screening and proactive disease management for use in remote and out-of-clinic care.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.